A Study on Left Ventricular Mass in Patients with Hypertension.
10.4070/kcj.1991.21.4.706
- Author:
Im Jak HONG
;
Suk Young PARK
;
Hyun Jo MIN
;
Kyong Saeng LEE
;
Young Woo LEE
;
Chang Sup SONG
- Publication Type:Original Article
- Keywords:
Hypertension;
Left ventricular mass;
Antihypertensive drugs
- MeSH:
Antihypertensive Agents;
Atenolol;
Calcium Channels;
Captopril;
Cardiovascular Diseases;
Diuretics;
Echocardiography;
Follow-Up Studies;
Heart Failure;
Humans;
Hydrochlorothiazide;
Hypertension*;
Hypertrophy;
Methyldopa;
Peptidyl-Dipeptidase A;
Vasodilator Agents
- From:Korean Circulation Journal
1991;21(4):706-714
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Hypertension is a well known causative factor of congestive heart failure and other cardiovascular disease, and usually induce myocardial hypertrophy. Recent study shows that some antihypertensive drugs may reduce the hypertrophied cardiac mass reversibly. And over the past some decades, increasing attention was focused on these drugs. These drugs include methyldopa, angiotensin converting enzyme inhibitor, calcium channel inhibitor, beta-adrenergic blocker, but diuretics and vasodilators were known not to reduce the hypertrophied ventricular mass. In this study, 46 hypertensive patients were managed by captopril, atenolol, or hydrochlorothiazide monotherapy. And wer estimated and follow up LV mass by echocardiography during 3 months. Captopril and atenolol group showed LV mass reduced, but hydrochlorothiazide group did not. LV mass was reduced more in captopril group than in atenolo group. In conclusion, we have been impressed by this study that diuretics monotherapy for hypertension shoud be reconsidered. And we concluded that drugs which can reduce myocardial mass shoud be chosen to control hypertension as a monotherapeutic drug or a additive drug.
